Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer

References

• Allensworth JL, Aird KM, Aldrich AJ, et al. (2012). XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Mol Cancer Ther 11:1518–27.
   PubMed Web of Science ®Google Scholar
• Aruffo A, Stamenkovic I, Melnick M, et al. (1990). Cd44 Is the principal cell surface receptor for hyaluronate. Cell 61:1303–13.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33:941–51.
   PubMed Web of Science ®Google Scholar
• Brewster AM, Chavez-MacGregor M, Brown P. (2014). Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Lancet Oncol 15:e625–34.
   PubMed Web of Science ®Google Scholar
• Cao N, Cheng D, Zou S, et al. (2011). The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials 32:2222–32.
   PubMed Web of Science ®Google Scholar
• Dorsey JF, Mintz A, Tian XB, et al. (2009). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Mol Cancer Ther 8:3285–95.
   PubMed Web of Science ®Google Scholar
• Farooqi AA, Gadaleta CD, Ranieri G, et al. (2016). New frontiers in promoting TRAIL-mediated cell death: focus on natural sensitizers, miRNAs, and nanotechnological advancements. Cell Biochem Biophys 74:3–10.
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Smith IE, Reis-Filho JS. (2010). Triple-negative breast cancer. N Engl J Med 363:1938–48.
   PubMed Web of Science ®Google Scholar
• Gotte M, Yip GW. (2006). Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66:10233–7.
   PubMed Web of Science ®Google Scholar
• Kagawa S, He C, Gu J, et al. (2001). Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 61:3330–8.
   PubMed Web of Science ®Google Scholar
• Kischkel FC, Lawrence DA, Chuntharapai A, et al. (2000). Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611–20.
   PubMed Web of Science ®Google Scholar
• Kischkel FC, Lawrence DA, Tinel A, et al. (2001). Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276:46639–46.
   PubMed Web of Science ®Google Scholar
• Lei C, Cui Y, Zheng L, et al. (2013). Development of a gene/drug dual delivery system for brain tumor therapy: potent inhibition via RNA interference and synergistic effects. Biomaterials 34:7483–94.
   PubMed Web of Science ®Google Scholar
• Lemke J, von Karstedt S, Zinngrebe J, et al. (2014). Getting TRAIL back on track for cancer therapy. Cell Death Differ 21:1350–64.
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Zhu Y, et al. (2013). Recent advances in delivery of drug-nucleic acid combinations for cancer treatment. J Control Release 172:589–600.
   PubMed Web of Science ®Google Scholar
• Luo C, Miao L, Zhao Y, et al. (2016). A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA. Biomaterials 102:239–48.
   PubMed Web of Science ®Google Scholar
• MacFarlane M. (2003). TRAIL-induced signalling and apoptosis. Toxicol Lett 139:89–97.
   PubMed Web of Science ®Google Scholar
• Prasad S, Kim JH, Gupta SC, et al. (2014). Targeting death receptors for TRAIL by agents designed by mother nature. Trends Pharmacol Sci 35:520–36.
   PubMed Web of Science ®Google Scholar
• Surace C, Arpicco S, Dufay-Wojcicki A, et al. (2009). Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Mol Pharm 6:1062–73.
   PubMed Web of Science ®Google Scholar
• Teo PY, Cheng W, Hedrick JL, et al. (2016). Co-delivery of drugs and plasmid DNA for cancer therapy. Adv Drug Deliv Rev 98:41–63.
   PubMed Web of Science ®Google Scholar
• Tsai WS, Yeow WS, Chua A, et al. (2006). Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin. Mol Cancer Ther 5:2977–90.
   PubMed Web of Science ®Google Scholar
• Turner NC, Reis-Filho JS. (2013). Tackling the diversity of triple-negative breast cancer. Clin Cancer Res 19:6380–8.
   PubMed Web of Science ®Google Scholar
• Vlodavsky I, Friedmann Y, Elkin M, et al. (1999). Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793–802.
   PubMed Web of Science ®Google Scholar
• Wang LH, Li Y, Yang SN, et al. (2014). Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling. Br J Cancer 110:341–52.
   PubMed Web of Science ®Google Scholar
• Wang S, Ren W, Liu J, et al. (2010). TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo. Clin Cancer Res 16:2591–604.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang L, Chen M, et al. (2015). Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression. Chem Biol Interact 235:76–84.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang J, Wang Y, et al. (2016). Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Nanomedicine 12:411–20.
   PubMed Web of Science ®Google Scholar
• Wiley SR, Schooley K, Smolak PJ, et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673–82.
   PubMed Web of Science ®Google Scholar
• Wu X, Wang S, Li M, et al. (2017). Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy. Nanoscale 9:13879–904.
   PubMed Web of Science ®Google Scholar